Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ALI HEALTH
00241
5
TRIP.COM-S
09961
JP Stock MarketDetailed Quotes
Takeda Pharmaceutical (4502)
- 5087.0
- +135.0+2.73%
20min DelayNot Open Jan 8 15:30 JST
8.09TMarket Cap75.67P/E (Static)
5089.0High4987.0Low6.32MVolume4999.0Open4952.0Prev Close31.94BTurnover5089.052wk High0.41%Turnover Ratio1.59BShares3916.052wk Low20.57EPS TTM7.78TFloat Cap8080.0Historical High75.67P/E (Static)1.53BShs Float2894.5Historical Low67.23EPS LYR2.06%Range %198.00Dividend TTM1.13P/B100Lot Size3.89%Div Yield TTM
Takeda Pharmaceutical (4502) Cash Flow
Quarterly+Annual
YOY
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 34.62%378.23B | 26.49%215.42B | 47.58%1.06T | -20.25%222.16B | 162.04%383.76B | 41.25%280.96B | 84.31%170.3B | -26.69%716.34B | -5.14%278.59B | -61.28%146.45B |
| Net income from continuing operations | -112.73%-11.73B | 30.41%124.28B | -25.00%108.14B | -3,343.49%-103.1B | -77.46%23.84B | 292.01%92.11B | 6.59%95.3B | -54.52%144.2B | -109.62%-2.99B | -11.24%105.76B |
| Operating gains losses | 214.66%2.38B | -389.36%-16.78B | 79.20%-1.72B | 77.38%-1.6B | 518.40%2.55B | 134.50%757M | -674.37%-3.43B | -550.25%-8.25B | -3,827.22%-7.07B | -63.84%413M |
| Depreciation and amortization | -3.88%184.98B | -5.51%181.64B | 4.59%761.4B | 1.62%189.77B | -0.06%186.96B | 5.34%192.45B | 12.08%192.22B | 9.57%728B | 15.70%186.74B | 5.76%187.06B |
| Asset impairment expenditure | 742.38%84.79B | -90.93%2.36B | -28.99%106.53B | 334.05%68.3B | -71.47%2.16B | -91.53%10.07B | 232.10%26B | 132.97%150.02B | -29.83%15.74B | 25.90%7.58B |
| Unrealized gains and losses of investment securities | -89.70%225M | 6,466.67%764M | -102.90%-602M | -135.76%-2.86B | -99.37%81M | 1,225.77%2.18B | -127.27%-12M | 420.10%20.76B | 2,504.82%7.98B | 233.32%12.92B |
| Remuneration paid in stock | -13.10%18.73B | 7.44%16.53B | 2.82%72.87B | -3.08%17.63B | -2.17%18.3B | 16.29%21.55B | -0.36%15.39B | 16.81%70.87B | 22.49%18.19B | 13.45%18.71B |
| Deferred tax | 46.35%39.9B | -36.20%26.35B | 173.23%66.94B | 90.57%-4.2B | 105.78%2.57B | 156.79%27.27B | -9.47%41.3B | -257.46%-91.41B | -365.38%-44.53B | -270.92%-44.5B |
| Other non cashItems | 65.22%90.37B | 34.36%-53.02B | -4.24%153.41B | 28.13%103.64B | 5.47%75.85B | 30.46%54.7B | -133.98%-80.77B | 789.71%160.2B | 208.01%80.88B | 0.98%71.91B |
| Change In working capital | 130.98%21.94B | 57.98%-33.7B | 76.81%-59.37B | -95.16%2.87B | 153.46%88.76B | -4,553.46%-70.81B | 46.87%-80.19B | -913.31%-256B | -58.59%59.38B | -423.60%-166.02B |
| -Change in receivables | 2.37%-9.8B | 200.71%48.08B | -490.35%-58.96B | -118.75%-13.85B | -11.30%12.67B | -158.03%-10.04B | 47.17%-47.74B | -79.90%15.1B | 8.24%73.9B | 11.88%14.29B |
| -Change in inventory | 29.60%-28.96B | -29.67%-13.07B | 69.78%-34.97B | -139.16%-4.99B | 142.01%21.24B | 16.64%-41.14B | 64.75%-10.08B | -46.22%-115.74B | 128.38%12.75B | -173.82%-50.55B |
| -Change in payables and accrued expense | 4,298.40%16.54B | 25.83%-27.78B | 28.06%-7.12B | 133.89%10.33B | -72.06%19.63B | 102.50%376M | -8.08%-37.46B | 88.33%-9.9B | -150.66%-30.48B | 1,011.24%70.27B |
| -Change in other current liabilities | 146.26%12.22B | -295.57%-17.53B | 81.21%-3.49B | 171.41%6.11B | 117.78%7.86B | -396.04%-26.42B | -64.50%8.96B | -158.63%-18.57B | -121.61%-8.55B | -210.03%-44.19B |
| -Change in other working capital | 398.47%31.94B | -482.42%-23.4B | 135.59%45.17B | -55.12%5.28B | 117.56%27.36B | -83.88%6.41B | 127.10%6.12B | -497.82%-126.9B | -42.01%11.77B | -734.91%-155.83B |
| Tax refund paid | -8.22%-53.36B | 7.06%-33B | 25.55%-150.41B | -35.16%-48.3B | 63.47%-17.31B | 25.68%-49.31B | 32.48%-35.5B | -8.64%-202.04B | -70.96%-35.73B | 15.17%-47.38B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 34.62%378.23B | 26.49%215.42B | 47.58%1.06T | -20.26%222.16B | 162.04%383.76B | 41.25%280.96B | 84.31%170.3B | -26.69%716.34B | -5.14%278.59B | -61.28%146.45B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 35.93%-48.13B | 78.82%-33.19B | 20.87%-367.06B | 67.99%-19.68B | -53.53%-115.56B | -24.02%-75.13B | 41.21%-156.69B | 23.59%-463.86B | 85.98%-61.49B | -61.20%-75.27B |
| Net PPE purchase and sale | 18.91%-40.1B | 27.69%-41.53B | -20.32%-200.72B | -9.49%-48.76B | 3.70%-45.08B | -67.49%-49.44B | -25.00%-57.43B | -19.41%-166.81B | -27.65%-44.53B | -39.82%-46.81B |
| Net intangibles purchas and sale | 53.35%-12.73B | 71.73%-27.16B | 41.43%-178.83B | -121.99%-43.93B | 61.51%-11.56B | 15.25%-27.29B | 56.98%-96.05B | 38.08%-305.31B | 95.15%-19.79B | -75.09%-30.04B |
| Net business purchase and sale | -92.26%417M | 895.95%29.29B | 287.01%77.24B | 245.27%67.65B | --1.26B | 77,085.71%5.39B | 690.59%2.94B | 150.80%19.96B | 146.22%19.59B | --0 |
| Net investment purchase and sale | 116.76%1.33B | 108.56%913M | -155.71%-81.94B | 102.39%678M | -3,097.30%-64.01B | -429.09%-7.95B | -8,038.93%-10.66B | -364.77%-32.05B | -844.17%-28.41B | -242.39%-2B |
| Dividends received (cash flow from investment activities) | 33,300.00%334M | 21.36%250M | -95.19%635M | -99.76%31M | 3.39%397M | --1M | 40.14%206M | 270.33%13.19B | 3,759.76%12.66B | -53.11%384M |
| Interest received (cash flow from investment activities) | -40.91%2.88B | 11.98%4.85B | 58.23%17.66B | 48.70%4.34B | 31.28%4.13B | 75.07%4.87B | 86.52%4.33B | 120.83%11.16B | 28.91%2.92B | 135.25%3.14B |
| Net other investing changes | 62.45%-267M | 788.89%186M | 72.28%-1.11B | 107.98%313M | -1,187.30%-685M | -434.59%-711M | -92.86%-27M | -31.19%-4B | -38.37%-3.92B | -83.85%63M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 35.93%-48.13B | 78.82%-33.19B | 20.87%-367.06B | 67.99%-19.68B | -53.52%-115.56B | -24.02%-75.13B | 41.21%-156.69B | 23.59%-463.86B | 85.98%-61.48B | -61.21%-75.27B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 89.11%-11.98B | -167.92%-214.9B | -112.02%-751.42B | -418.33%-301.79B | -571.00%-655.97B | 21.76%-110.04B | 647.58%316.38B | 50.02%-354.42B | -782.03%-58.22B | 77.52%-97.76B |
| Net issuance payments of debt | 152.56%36.56B | -99.99%22M | -20,874.22%-314.31B | -1,325.48%-203.5B | -740.71%-470.88B | 55.72%-69.55B | 332.35%429.61B | 100.53%1.51B | -149.19%-14.28B | 127.61%73.49B |
| Net common stock issuance | --0 | -2,641.92%-51.6B | -2,129.58%-51.86B | ---49.98B | --0 | --0 | 19.09%-1.88B | 91.36%-2.33B | --0 | --0 |
| Cash dividends paid | 4.48%-8.79B | -5.20%-145.3B | -5.33%-302.5B | -6.71%-9.74B | -5.21%-145.45B | -1.48%-9.2B | -5.63%-138.11B | -2.78%-287.19B | 12.41%-9.13B | -7.18%-138.25B |
| Interest paid (cash flow from financing activities) | -32.69%-35.6B | -7.93%-16.69B | -12.56%-112.98B | -60.80%-34.88B | -23.59%-35.81B | 10.25%-26.83B | 21.95%-15.47B | 7.54%-100.38B | 1.37%-21.69B | 14.39%-28.97B |
| Net other financing activities | 7.21%-4.15B | -103.15%-1.33B | -10.98%30.23B | 71.85%-3.7B | 4.87%-3.83B | -108.07%-4.47B | 1,091.92%42.23B | 470.06%33.96B | -308.68%-13.13B | 31.98%-4.03B |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 89.11%-11.98B | -167.92%-214.9B | -112.02%-751.43B | -418.34%-301.79B | -571.00%-655.97B | 21.76%-110.05B | 647.58%316.38B | 50.02%-354.42B | -782.17%-58.22B | 77.52%-97.76B |
| Net cash flow | ||||||||||
| Beginning cash position | -56.52%350.01B | -15.88%385.11B | -14.19%457.8B | 71.36%494.13B | 170.09%859.02B | 154.44%805.01B | -14.19%457.8B | -37.21%533.53B | -57.91%288.36B | -60.15%318.05B |
| Current changes in cash | 232.11%318.11B | -109.90%-32.67B | 39.86%-61.3B | -162.51%-99.31B | -1,359.04%-387.77B | 4,212.80%95.79B | 242.29%329.99B | 69.94%-101.93B | 204.94%158.88B | 74.30%-26.58B |
| Effect of exchange rate changes | 131.98%13.36B | -114.14%-2.44B | -143.45%-11.39B | -191.86%-9.7B | 834.48%22.88B | -1,144.60%-41.78B | 16.67%17.22B | 14.28%26.2B | 5,081.13%10.56B | 67.48%-3.12B |
| End cash Position | -20.67%681.49B | -56.52%350.01B | -15.88%385.11B | -15.88%385.11B | 71.36%494.13B | 170.09%859.02B | 154.44%805.01B | -14.19%457.8B | -14.19%457.8B | -57.91%288.36B |
| Free cash from | 59.35%325.4B | 734.80%140.36B | 187.57%677.56B | -39.59%129.44B | 371.83%327.11B | 58.47%204.2B | 109.51%16.81B | -31.40%235.61B | 242.47%214.26B | -78.84%69.33B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"